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Abstract
Background: Sphenoid wing meningiomas extending to the orbit (ePMSW) are 
currently removed through several transcranial approaches. Presenting the largest 
surgical cohort of hyperostosing ePMSW with the longest follow up period, we will 
provide data supporting minilateral orbitotomy with excellent exposure for wide 
resection of all compartments of the tumor.
Methods: A retrospective survival analysis is made of the data cumulated 
prospectively during a period of 34 years, including 88 cases of ePMSW with 
a mean follow up period of 136.4 months. The impact of preoperative variables 
upon different outcome measures is evaluated. Standard pterional craniotomy was 
performed in 12 patients (C) while the other 76 cases underwent the proposed 
modified lateral miniorbitotomy (LO).
Results: There were 31 men and 57 women. The age range varied between 12 and 
70 years. Patients presented with unilateral exophthalmos (Uex) ranging between 
3 and 16 mm. Duration of proptosis before operation varied between 6 months 
and 16 years. The status of visual acuity (VA) prior to operation was: no light 
perception (NLP) in 16, light perception (LP) up to 0.2 in 3, 0.3–0.5 in 22, 0.6–0.9 in 
24, and full vision in 23 patients. Postoperatively, acceptable cosmetic appearance 
of the eyes was seen in 38 cases and in 46 mild inequality of < 2 mm was detected. 
Four cases had mild enophthalmos (En). Among those who had the worst VA, two 
improved and one became almost blind after operation. The cases with VA in the 
range of 0.3–0.5 improved. Among those with good VA (0.5 to full vision), 2 became 
blind, vision diminished in 10, and improved or remained full in the other 35 cases. 
Tumor recurrence occurred in 33.3% of group C and 10.5% of group LO (P = 0.05). 
The major determinant of tumor regrowth was the technique of LO (P = 0.008).
Conclusion: Using LO technique, the risky corners involved by the tumor is 
visualized from the latero‑inferior side rather than from the latero‑superior avenue. 
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INTRODUCTION
Sphenoid wing (SW) en plaque meningioma (ePM) 
is a subgroup of meningiomas defined by its specific 
character presenting with a rather thin sheath of soft 
tumor tissue accompanied by disproportionate and 
extensive bone hyperostosis. ePMs may occur anywhere 
along the central nervous system (CNS).[13,43] It comprises 
2–9% of all meningiomas, which are located mainly along 
the SW.[5,20,45] Cushing and Eisenhardt[13] coined the 
term of “en plaque” for the first time to differentiate 
this type of tumor growth from those designated as 
“en mass” meningiomas. Hyperostosis of the greater and 
lesser wings of the sphenoid bone leading in progressive 
proptosis is the main characteristics of ePM in this 
location. Whether this hyperostosis is due to: (a) Tumor 
invasion, (b) reactive hyperostosis, or (c) a mixture of 
both types of affections, varies in different series and 
the concept of its development has not yet reached to a 
uniform consensus.[5,10,20,26,29,32,37,39]
In this retrospective analysis of a prospective acquisition 
of database including 88 consecutive cases of what is 
called ePM of the sphenoid wing (ePMSW), we will 
present and discuss: (i) The reasons for changing our 
attitude in surgical technique, (ii) analyze the impact 
of variants upon the long‑term follow up results of the 
patients with the end point of focal tumor recurrence, 
and (iii) it will be hypothesized that the term of 
‘ePMSW’ should only be specified for a single group of 
‘ePM’ of the SW with specific characteristics.
CLINICAL MATERIAL AND METHODS
Inclusion criteria and patient population
Among all the patients undergoing surgical intervention 
with the diagnosis of unilateral exophthalmos (Uex) in 
the section of skull base surgery (451 cases) there were 
88 patients who fulfilled the criteria to be included 
in this study. Close cooperation between different 
specialties joined in our skull base interdisciplinary 
team, which included neurosurgeons, neurologist, 
neuro‑ophthalmologist, neuro‑otologist, neuro‑radiologist, 
and neuro‑pathologist, and was the main reason that 
made this study a reasonable and watchful bench.
We included all the patients admitted with the diagnosis 
of Uex whose histopathology report was meningioma 
with involvement of the sphenoid bone. There were two 
cases with multiple meningiomas/meningiomatosis and 
were excluded from this series.
The selection criteria were:
•	 Hyperostosis of the greater/lesser wing of the 
sphenoid bone. This usually involved the pterional 
synostosis, the lesser and the greater SWs above and 
below the superior orbital fissure (SOF) and could 
involve the elements of the ipsilateral clinoid process 
and optic foramen
•	 Enhancement of the soft tissue of the tumor is 
visible in postcontrast enhancing T1W magnetic 
resonance imaging (MRI), located mainly along the 
SW and around the orbital fissure. The soft tissue 
tumor could be visible within the cone and lateral 
compartment of the orbit and also extend underneath 
the temporalis muscle extracranially. Extension 
of tumor tail could also exist along the ipsilateral 
clinoid, in the subfrontal region over the roof of 
the orbit, toward the cavernous sinus and its lateral 
wall, enhancing the wall of the sphenoid or ethmoid 
sinuses, and ensheathing the dura of the subtemporal 
fossa extending toward the petrous surface
•	 If there were no hyperostosis of the elements of the 
SW, or the tumor mass was mainly located around 
the anterior clinoid process (ACP) or enrooted 
from within the cavernous sinus or was mainly a 
variant of optic nerve sheath tumor or was a pure 
meningioma of the lateral/mid 3rd of the SW, they 
were excluded.[35,37,39,45]
The study period was 34 years, from June 1979 to June 
2013.
Neurological and ophthalmological examination
All patients underwent complete pre‑ and postoperative 
neurological examinations and signs and symptoms 
denoting the duration of illness were recorded. 
Visual acuity (VA) (Snellen notation), visual 
field (VF) (Goldmann or Humphrey perimetery), 
and funduscopy were all performed by the 
neuro‑ophthalmologist.
Imaging evaluations
The preoperative neuroradiological evaluation was 
performed in all cases. MRI, computed tomography (CT) 
and 3‑dimensional reconstruction CT scan (3DRCTS) 
were all reported by the neuro‑radiologist.
This is the crucial milestone to achieve aggressive removal of all the involved 
compartments of the lesion. Satisfactory cosmetic result is reported using mini LO 
technique after widely exposing and removing the hyperostotic bone down to the 
subtemporal fossa with only simple repair of the dura without cranioplasty.
Key Words: Lateral orbitotomy, meningioma, orbital tumors, proptosis, sphenoid 
wing meningioma, spheno‑orbital meningioma, unilateral exophthalmos.
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Infiltration and enhancement of the periorbita, dura 
mater of the temporal fossa, cavernous sinus, and the 
extra‑calvarial soft tissue were assessed on postcontrast 
MR images, while osseous extension was assessed on CT 
scans before and after contrast enhancement.
All of the ePMs in this series presented with the four 
radiological characteristics defined as: (a) Hyperostosis 
of the wings of the sphenoid, (b) enhancement of 
the soft tissue of the periorbita (pod 1), (c) variable 
enhancement of the dura of the temporal fossa 
(pod 2), and (d) enhancement of the soft tissue 
beneath the temporalis muscle highly suspicious for 
extra‑calvarial involvement of the tumor (pod 3). 
According to the above findings, the nomination of 
‘tripodal meningioma’ will be appropriated. Based on the 
different degrees of involvement of other compartments 
besides the above‑mentioned structures, we selected the 
term of ‘radiologically invasive ePM’ (RIePM) for those 
cases [Table 1].
The cases with only tripodal enhancement in MRI 
were designated as ‘low tumor infiltration.’ Those with 
extension to the subfrontal and olfactory groove and 
along the cavernous sinus were designated as ‘moderate 
tumor infiltration’ and those with tumor extension or tail 
to the paranasal and sphenoid sinuses, to the extracranial 
parapharyngeal and subtemporal regions, crossing the 
midline in the anterior fossa are coined as ‘high tumor 
infiltration’ [Table 1].
Clinical and radiological follow up
It was presumed that all patients undergo clinical follow‑up 
with complete visual and neurological examinations 
and cerebral MR/CT imaging on a regular basis every 
6–12 months after primary intervention. To analyze the 
extent of surgical tumor removal, operative notes were 
reevaluated regarding the amount of bone removal and 
resection of intradural or intraorbital tumors. The first 
and last clinical examination and imaging taken in the 
follow‑up period were compared in this study and the 
clinical and radiologic findings were measured numerically 
and by observation of the variables [Table 2]. Regarding 
the long distances between the cities, travelling costs 
and other socio‑economic problems in the third world, 
constant, regular, and matched follow up dates/data could 
not be extracted from the files. Patients and their close 
relatives were called to obtain further follow up data 
when necessary. The follow up period varied between 
5 and 348 months (median = 141, mean = 136, 
SD = 107 months).
Surgical intervention
The patient’s head is fixed in a 3‑pin Mayfield head 
holder and is rotated 30° to 45o to the contralateral 
side. Brain relaxation and control of intraglobal 
pressure was maintained using dehydrating agents and 
moderate hyperventilation prior to and during surgery. 
A S‑shaped skin incision is made starting from within the 
eyebrow, along the lateral 3rd and down to the extreme 
lateral end of the lateral canthus, and then turned 
horizontally along the zygomatic arch to a finger width 
distance in front of the tragus to prevent any damage 
to the frontal branch of the facial nerve [Figure 1]. 
A curved incision is then made through the periosteum of 
the frontozygomatic bone. The bulk of temporalis muscle 
filling up the temporal fossa is dissected subperiosteally, 
taking care to control the bleeding from the possibly 
hypertrophied meningeal branches and the tumor carpet 
infiltrating the periosteum of the temporal bone. Using 
a periosteal elevator, the periorbital fascia is shaved off 
the lateral wall of the orbit, which is usually a bulky and 
nonhomogenously ragged bone infiltrated by the tumor 
tissue and is adherent to the orbital fascia. This maneuver 
should be performed very carefully not to damage the 
periorbital fascia. A reciprocating saw is used to incise 
the lateral rim of the orbit just above the frontozygomatic 
suture line and to make another cut just above the 
horizontal part of the zygomatic arch, both in a converging 
oblique direction. An assistant must carefully protect the 
intraorbital contents with a malleable retractor inserted 
between the inner surface of the lateral wall of the orbit 
and the periorbital fascia. Then, a rongeur is used to grasp 
the rim of the orbit and break it from the greater wing 
of sphenoid. The hyperostotic bone starts usually from 
this point and can be rongeured along the greater wing of 
Table 1: Different types of ePMs presenting with Uex 
sub-divided according to the localization of the visible 
tumor in MRI at the time of referral
Type of involvement No.
Tripodal 65
Recurrent tripodal 5
Tripodal + extension to the olfactory groove 2
Tripodal + extension to sphenoid sinus 3
Invasive type 5
Tripodal + extension to the olfactory groove, sphenoid cell and 
petrous bone
1
Tripodal + extension to sphenoid and ethmoid cells 1
Tripodal + extension to the subtemporal region 1
Tripodal + extension to the cavernous sinus, subtemporal and 
petrous regions
1
Tripodal + clinoidal tumor 2
Tripodal + clinoidal tumor and extension to the olfactory 
groove
1
Tripodal + ipsilateral occipital AVM 1
Total 88
By ‘Tripodal’ we nominated the cases with: (a) enhancing soft tumor detectable as a 
sheath extending along the squamosa of the temporal bone underneath the temporalis 
muscle extracranially, (b) tumor along the SW extending to the parasellar region, and 
(c) tumor within the orbital cavity (‘low tumor infiltration’). The others in the list 
were (‘moderate tumor infiltration’) or (‘high tumor infiltration’). SW: Sphenoid wing, 
AVM: Arteriovenous malformation
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the sphenoid. The bulk of the temporalis muscle should 
be kept retracted as much as possible to expose all the 
hyperostotic, out bulging lateral and down looking surface 
of the temporal bone with the out‑merging tumor mass 
covering the outer surface of it. Using a high speed drill 
and a fine angled rongeur, the hyperostotic bone should 
be removed until the normal looking bone reached, 
that is, adjacent to the temporalis line upwards, above 
the ear backwards and along the floor of the temporal 
fossa over the roof of the subtemporal compartment. 
The thickened bone is often a kind of so called ‘marble 
bone’ and its drilling is time consuming. It may be very 
hypervascular in some cases and frequent application of 
bone wax for hemostasis can be boring. Samples should 
be taken from all segments of this bone to look for tumor 
infiltration as a separate pathology specimen. Completion 
of bone work exposes: (a) The anterior temporal dura, 
most of the inferior temporal dura and all the adjacent 
normal looking dura mater in the frontal and low parietal 
region and posterior to the base of the tumor. In this 
stage, the pathology appears as antero‑inferiorly based 
temporal ePM, similar to a convexity meningioma in 
gross exposure, (b) a good visualization of the periorbital 
fascia and retrobulbar contents is also achieved, (c) 
the surgeon looks at the greater and lesser wings of the 
sphenoid bone from an inferolateral direction so that the 
hypertrophied/sclerotic wings can be drilled as deep and 
down as necessary [Figure 2], (d) the SOF can be seen 
from above, lateral and below preserving the vital neural 
elements. Using microscopic dissection, one can eliminate 
as much of the tumor as possible [Figure 2], and (e) 
drilling the lesser wing in the depth and along the roof 
of the orbit under microscope can facilitate removing 
the lateral strut of the ACP and decompress the optic 
foramen in its superolateral aspect [Figure 3]. In the 
cases with visual impairment, decompression of the optic 
nerve has been performed extradurally in this series. It is 
not suggested to open the optic nerve sheath in any of 
the cases. If air cells are opened, they should be sealed 
up properly using autologous fat and muscle covered by 
Gelfoam, Surgicel, or glue.
The intradural component of the tumor can be 
removed solely by cutting the dura along the normal 
Table 2: The clinical status of the patients before and after surgical intervention
Symptom Preop. N (%) Postop. Results and complications
Uex. (proptosis) 88 (100) Remission all cases Normal=38, 3‑4 mm=46, mild en,=4
Temporal swelling 88 (100) disappeared Atrophy of temporalis muscle=14
Visual acuity NLP=16
LP‑0.2=3
0.3‑0.5=22
0.6‑0.9=24
Full vision=23
LP=3
2=improved, 1=NLP
18=improved, 4=LP
2=NLP, 6=worsened, 16=improved
4=decreased to 0.5‑0.6
All improved 0.1‑0.2 during the follow up 
except those NLP at presentation
Painful proptosis 28 cases No further pain
Reddening of the sclera 4 cases Improved gradually
Optocilliary shunt 4 cases No change
Remarkable edema of 
the eyelids
2 cases improved
EOMP 0, except mild medial deviation 
of the globe
Improved=52
Lateral gaze paresis=21
Panophthalmoparesis=4
Panophthalmoplegia=1
OK
Acceptably improved in all cases
Acceptably improved in all cases
No change
Tear production Not affected No change No corneal damage even after radiotherapy
Epilepsy 1+ temporal lobe edema in MRI 1 No medication after 8 months
Papilledema 18 cases Improved 
Atrophy of temporalis 
muscle
0, no obvious sign of Vth. 
N palsy
6 cases Appeared in late follow up
NLP: No light perception, LP: Light perception, EOMP: Extraocular muscle palsy
Figure 1:  Line of incision, before the patient was anesthetized and 
head fixed. Shaving the hair is not necessary
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looking boundary of the tumor in all directions. Two 
points should be highlighted in this stage: (i) Delicate 
dissection of dura should be done around the SOF with 
careful coagulation of the dural folds infiltrated by the 
tumor to decrease the amount of residual tumor cells 
in the vicinity of the orbital fissure and (ii) the entire 
tumoral infiltration of the dura at the base of frontal 
lobe and over the roof of the orbit, the involved dura 
of the temporal fossa in its anterior, inferior, and medial 
or internal part located along the lateral wall of the 
cavernous sinus should be either removed or curetted 
and coagulated.
The orbital compartment of the tumor can either be seen 
or palpated at this stage. Extension of the tumor to the 
roof, along the most inferior part and toward the cone of 
the orbit, can be dissected and removed with this exposure. 
Reduction of the tumor mass can be achieved using either 
piece meal technique or using ultrasonic aspirator. It is 
better to leave tumor spicules behind especially in the 
cone of the orbit where the elements entering the orbit via 
SOF might be infiltrated by the tumor cells.
Dural repair can be done with a large patch of pericranial 
graft removed from the temporo‑parietal region and 
sutured only in some points, and covered with Gelfoam 
or Surgicel. Neither the roof, the lateral wall of the orbit 
nor the defect of the temporal bone was reconstructed 
in any of our cases. The bone strut removed from 
the orbito‑zygomatic arch is replaced and fixed in an 
appropriate and feasible way and periosteum sutured 
over it. Vacuum drain with moderate negative pressure is 
placed underneath the temporalis muscle for 48 h. Skin 
is sutured in subcuticular manner. Lumbar puncture is 
performed once or twice during the postoperative period 
to manage subgaleal cerebrospinal fluid (CSF) collection.
Illustrative cases
Case 1
A 69‑year‑old female was admitted with progressive left 
Uex of more than 6 years duration. The exophthalmos (Ex) 
was 7 mm with inwards and downwards displacement. It 
was irreducible and nonpainful without any extraocular 
muscle palsy (EOMP). VA was 0.4 on Snellen notation 
with some restriction of VF on Humphrey perimeter. 
In fundoscopy, optic disc was blurred and whitish 
discolored with no optocilliary shunt. CT scan with 
3D reconstruction identified hyperostotic greater and 
lesser SWs and part of the ACP in different views. The 
soft tumor tissue extended in a carpet fashion in the 
temporal fossa with a maximum thickness of 4–5 mm 
to the cavernous sinus but it did not infiltrate it. The 
intraorbital extension of the tumor was voluminous, 
compressing the optic nerve both within the optic 
foramen and the cone of the orbit. Weekly enhancing 
tumoral tissue was also present underneath the 
temporalis muscle. Another very thin enhancing carpet of 
tumor was also seen hanging from the lateral roof of the 
sphenoid sinus, which could be either tumor extension 
or congested mucosal coverage. Angiography performed 
in another center revealed moderate tumor blush fed 
through the branches of the external and internal 
carotid arteries [Figure 4]. A minilateral orbitotomy was 
performed as described above and a marble, hyperostotic 
bone rongeured/punched/drilled out so that the SOF 
released all. The ACP was removed using high speed 
fine diamond drill and small sharp curette until the 
Figure 3: The schematic drawing showing the rim of the orbit 
removed and refixed at the end (green shaded) and the segments 
of the hyperostotic bone, which is necessary to be drilled out in 
most of the cases to achieve complete excision of the possibly 
involved bony compartments around the SOF down to the inferior 
orbital fissure and to decompress the optic canal from the lateral 
side (red shaded)
Figure 2: Three dimensional bone formatted CTS of the skull along 
with the skull X-ray adjusted for each, defining the gates through 
which the hyperostotic bone is visualized (a and b black arrows in the 
circles) and the avenues through which the instruments can better 
reach the depth to remove decompress the involved/hyperostotic 
bone (black triple arrows in c, d and e), and the black triple arrows 
when approaching via standard/ pterional craniotomy (f) the view 
when is operated through the traditional pterional approach
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optic nerve sheath was exposed in the latero‑superior 
aspect. Most of the nonhomogenous solid tumor was 
removed from within the orbit down to the cone but 
small pieces infiltrating the muscles had to be left alone. 
The tumor sheath infiltrating the external periosteum 
of the temporal bone was removed and the hyperostotic 
temporal bone excised until the normal looking bone 
could be detected all around. Samples were taken from 
all the bone layers for histopathological study. The 
tumoral dura was removed until a clean looking margin 
was evident. The dura infiltrated by the tumor around 
the SOF was cut from the superomedial and inferolateral 
margin of the SOF and coagulated. The tumor was also 
teased off the lateral aspect of the cavernous sinus. All 
the dural margins were coagulated with low voltage 
bipolar cautery. The postero‑medial surface of the tumor 
had a fine and easily separable arachnoid membrane 
covering the temporal lobe. Two medium sized veins 
passed from the temporal cortex into the tumor and 
from there into the temporal sinusoids, which had to be 
coagulated. The operation ended with ‘Simpson grade II 
tumor excision.’ The temporal dura was repaired using 
autologous pericranium covered with Surgicel and no 
cranioplasty performed. None of the bone samples taken 
from the superficial or deepest part of the hyperostotic 
bone contained any tumor cells. Her postoperative course 
was uneventful and when visited after 3 months, the 
eyes were almost symmetrical and VA improved to 0.7 
with good VF. It was planned to deliver focal radiation 
therapy (FRT) after operation but she refused. There 
has been no sign of tumor recurrence during 3.5‑year 
follow‑up.
Case 2
This 56‑year‑old female was admitted with UeX of 4 years 
duration and VA of 0.6. Imaging showed remarkable 
hyperostosis of all the SW, normal looking ACP, and 
thin layer of enhancing soft tumoral tissue encasing the 
hyperostotic area. A very thin layer of soft tissue thickening 
was visible both in CT scan and MRI just in the vicinity 
of the mucosal layer of the sphenoid sinus [Figure 5]. The 
operation was done using the same minilateral orbitotomy 
and the same steps were undertaken. The bone was 
infiltrated by the meningioma cells in the superficial layers 
but the deeper hyperostotic areas were totally clean of 
tumor. There has been no sign of recurrence after 3.5 years.
Case 3
An 81‑year‑old male was admitted on June 2004 with 
left Uex. In May 1994 he underwent craniotomy in 
another center for SOM presenting with Uex and 
decreased vision secondary to a tumor mass arising 
from the left SW with hyperostosis visible in contrast 
Figure 4: (a and b) contrast enhanced CTS and MRI showing the 
intraorbital, temporal intra- and extra-cranial (small white arrow) 
of the tumor, c and d) three dimensional imaging of the face 
demonstrating the pattern of EX in (c), and bony cavity of the orbits 
showing asymmetric orbital fissures and squeezing of the left orbital 
fissure by the hyperostotic lesser and greater wings of the sphenoid 
bone (black arrow) in (d). (e) is the coronal view mainly illustrating 
the hperostotic ACP while (f) demonstrates hyperostosis of lesser 
and greater wings of the sphenoid bone and asymmetric orbital 
fissures. (g) is the lateral view of DSA showing the tumor blush 
located in the anterior temporal region. It is mainly fed through 
the meningeal branches of the ascending pharyngeal artery and the 
cavernous branches of the internal carotid artery and recurrent 
meningeal branches of the ophthalmic artery
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Figure 5:  (a and b) horizontal and coronal views of CTS hyperostotic 
wings of the SW and temporal squamosal plate and asymmetric 
orbital fissures squeezed in the left side without affection of ACP, 
(c and d) contrast-enhanced MRI elucidating a thin layer of tumoral 
tissue enhancement along the SW and subfrontal dura, underneath 
the temporalis muscle and highly suspicious for extending into the 
orbit. There is a bright sclerotic thickening within the posterior 
ethmoid sinus in the left side (black star in a) and an enhancing 
soft tissue nodule located in rather the same area in the ethmoid 
region visible in MRI (c, white arrow)
dc
ba
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enhanced CT scans. He did well after the first operation 
but vision decreased and Ex reappeared after 6 years. 
New imaging revealed hyperostosis of the SW and 
enhancing tumor mass within the lateral compartment 
of the orbit extending along the wall of the cavernous 
sinus to the temporal tip, and beneath the temporalis 
muscle [Figure 6]. He was operated for the second time 
after 10 years using a minilateral orbitotomy approach. 
This time the hyperostotic SW was removed deep to the 
ACP and inferior orbital fissure. The intradural tumor 
could be excised and shaved off the cavernous sinus 
but the intraorbital component was tightly adherent 
to the muscles and the scar of the previous operation, 
which could not be excised completely. Both Uex and 
VF improved after operation. Regarding tumor residue, a 
course of FRT was delivered. There was no sign of tumor 
recurrence when he last visited after 9 years. His cosmetic 
status was also satisfactory with no sign of atrophy of the 
temporalis muscle [Figure 6i and j].
RESULTS
Before operation
There were 88 cases including 31 men and 57 women 
(M/F ratio of 1:1.8). The symptoms at presentation 
are summarized in Table 2. The age range varied 
between 12 and 70 years (median = 47, mean = 45.8, 
SD = 13.5). All presented with Uex ranging between 
3 and 16 mm (median = 7 mm, mean = 6 mm, 
SD = 2.3 mm) based on bedside standard 
exophthalmometry plus data extracted from MRI and/or 
CT scans. Proptosis occurred in the right side in 40 and in 
the left side in 48 patients. There was no case of bilateral 
spheno‑orbital meningioma (SOM) in this series. The 
duration of progression of proptosis prior to operation 
varied between 6 months up to 16 years (median = 3, 
mean = 3.6, SD = 3.3). Palpation of the eye could 
produce pain in 28 cases. The sclera was reddish in four 
and optocilliary shunt could be detected in fundoscopy 
in other four cases. Papilledema was detected in 18 cases 
preoperatively on neuro‑ophthalmological evaluation. The 
VA and VF of all the patients were measured before and 
after operation and were closely watched in the follow‑up 
period. The status of VA before operation was: No light 
perception (NLP) in 16 patients, light perception (LP) up 
to 0.2 in 3, 0.3–0.5 in 22, 0.6–0.9 in 24, and full vision in 
23 patients [Table 2]. EOMP was not a common finding 
in this series of patients even though mild downward 
and inward deviation of the globe was present almost in 
all cases. Cranial nerves III, IV, V, or any other one not 
seen in preoperative examination. History of epilepsy 
was present only in one patient who had moderate focal 
edema in ipsilateral temporal lobe in MRI.
Outcome
Mild En occurred in the few postoperative days and usually 
disappeared after removing the surgical drain. Regarding 
remission of Uex, the difference between the two eyes up 
to 1 mm was considered as ‘acceptable remission.’ There 
were 38 cases with acceptable cosmetic appearance of the 
eyes regarding the location of the globes, 46 cases with 
mild inequality of <2mm and 4 with mild En 2–4 mm 
when visited for the first time almost 3 months following 
operation. This remained unchanged to their last visit. 
Previously noted swelling of the temporalis muscle was 
not detectable any more. Three of the patients who were 
blind preoperatively gained LP during follow up visits. 
Figure 6:  (a and b) contrast-enhanced CTS available from the first admission showing the hyperostotic SW the tumor mass in the temporal 
and subfrontal regions before craniotomy, (c) contrast enhanced CTS in the 2nd admission showing the remainder of the hyperostotic 
ridge, enhancing tumor and persisting EX, (d and e) contrast-enhancing T1W coronal MRI in the 2nd admission demonstrating the site of 
previous craniotomy and bulging SW involved by the tumor recurrence, (f and g) CTS performed after second intervention via the lateral 
approach showing appropriate bony decompression of the orbit and regression of EX, (h) MRI confirming tumor remnant within the cone 
of the orbit, and (i and j) face of the patient after long follow-up with good cosmetic features and no atrophy of the temporalis muscle
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Among those who had a poor quality of vision, two 
improved and one became almost blind after operation 
with no further improvement. All the cases with VA in the 
range of 0.3–0.5 improved after operation. Among those 
with good VA (0.5 to full vision), 2 became blind, vision 
decreased in 10, and VA improved or remained unchanged 
in the other 35 cases [Table 2]. Local tenderness and pain 
of the eye and redness of the sclera improved gradually 
after operation but optocilliary shunts were persistently 
detected by the ophthalmologists in follow‑up studies. 
Remarkable edema of the eyelid happened in 2 cases, 
which improved after a month, but moderate atrophy of 
temporalis muscle was noted late in 14 cases.
On histopathological examination, the sphenoid bone 
was infiltrated by meningioma in 53 (60.3%) of the cases. 
There has been no early reoperation needed in this series. 
Tumor recurrence occurred in 12 cases but reoperation 
was needed in 2 cases.
Radiotherapy
Focal radiation was delivered in the cases with (a) visible 
tumor residue or regrowth in follow‑up imaging, (b) those 
with bone infiltration with tumor cells in pathological 
studies, and (c) patients with clinically evident Uex 
in the postop period (31 cases). No patient developed 
radiation‑induced retinopathy or pituitary insufficiency.
Statistical analysis
For statistical analysis, SPSS v 16.0 was used. To describe 
the study variables, descriptive statistical measures were 
calculated including frequency, percentile, mean, and 
standard deviation whenever appropriate. Independent 
t‑test was applied to compare the mean of continues 
variables between the two study groups. The association 
between two categorical variables was assessed using 
a Chi‑square test. Whenever one or two of the study 
variables was ordinal in scale, the Chi‑square for trend 
was applied. A multiple logistic regression was used to 
evaluate the determinants of the tumor recurrence as 
an outcome variable. For other two outcome variables, 
that is, improvement/cure of the Uex and improvement 
of VA, the multiple linear regression models was applied 
to assess the determinant factors. The P value less than 
0.05 (P < 0.05) was considered statistically significant.
Output of the analysis
This 34‑year follow‑up study includes findings related 
to 88 cases of ePM including 12 cases (13.6%) who 
underwent craniotomy (C) and 76 cases (86.4%) who 
underwent lateral miniorbitotomy (LO) approach. 
Radiotherapy was delivered to 8 cases (66.7%) in 
group C and to 23 cases (30.3%) in group LO. The mean 
follow‑up period was 179 months (±123.6) in group C, 
and 129.6 months (±103.0) in group LO.
Tables 2 and 3 demonstrate the characteristics of the 
study subjects in terms of demographic variables, tumor 
characteristics, signs and symptoms, outcomes of surgery, 
and complications both in categorical and numerical 
values.
Demographic variables
Eleven (91.7%) patients in group C and 
46 patients (60.5%) in group LO were 
female (P = 0.05). Mean age of the cases in C and 
LO groups were 47.0 years (±15.3) and 45.6 (±13.3), 
respectively (P = 0.76).
Tumor characteristics
Five cases (41.7%) in group C and 37 cases (48.7%) in 
group LO had tumor in their right orbit (P = 0.65). 
Invasion to bone was observed in 10 cases (83.3%) of 
group C and 43 cases (56.6%) of group LO (P = 0.11). 
Among group C, low, medium, and high bone 
infiltration were observed in 6 (50.0%), 3 (25.0%), 
and 3 (25.0%) of cases, respectively. The frequencies 
of the grade of tumor invasion in the LO group were 
as follow: 66 low‑grade cases (86.8%), 4 medium‑grade 
cases (5.3%), and 6 high‑grade cases (7.9%) [Table 3]. 
In general, the group LO had lower grade of tumor 
infiltration (P = 0.007).
Signs and symptoms
Duration of the symptoms prior to operation was 
47.0 months (±47.3) in group C and 43.3 months 
(±38.7) in group LO (P = 0.80). Five patients (41.7%) 
Table 3: Radiologic characteristics of the hyperostotic 
SW in this series
Hyperostosis in the imaging
Lesser wing 88
Greater wing 88
ACP 34*
Histopathology of the hyperostotic bone defined by tumor cell 
‘present +’ or ‘absent − ’ in the specimens from the SW in 
88 cases
+ in the specimens taken from the bone adjacent to the tumor 
and + in the specimens taken from the deeper hyerostotic 
region
31
+in the specimens taken from the bone adjacent to the tumor 
and‑in the specimens taken from the deeper hyerostotic region
43
− in the specimens taken from the bone adjacent to the tumor 
and‑in the specimens taken from the deeper hyerostotic region
14
Histopathology of the hyperostotic bone defined by tumor cell 
‘present + or absent − ’ in the specimens from the ACP in 
12 cases only
Positive + 4
Negative − 8
*=as reported in the available CT scans evaluated by one neuro-radiologist and two 
attending neurosurgeons. Definition of histopathological examination of the different 
layers of bone removed from the hyperostotic SW was: among the C (craniotomy) group, 
low, medium, and high bone infiltration were observed in 8 (66.7%), 4 (25.0%), and 1 
(8.3%) of cases, respectively. The frequencies of the grade of bone infiltration in the lateral 
orbitotomy group were as follows: 23 low-grade cases (30.3%), 39 medium-grade cases 
(51.3%), and 14 high-grade cases (18.4%). Generally, the LO group had higher grade of 
bone reaction to tumor (P=0.03). The rate of tumor infiltration to the specimens taken 
from ACPs of only 12 patients are also mentioned. SW: Sphenoid wing, CT: Computed 
tomography, LO: Lateral orbitotomy, ACP: Anterior clinoid process
Surgical Neurology International 2015, 6:79 http://www.surgicalneurologyint.com/content/6/1/79
in group C had pain, while that was experienced 
by 25 cases (32.9%) in group LO (P = 0.53). Five 
patients (6.6%) in group LO had eye redness and retinal 
shunt. None of these symptoms were observed in patients 
of the group C.
The mean of the amount of Uex before operation 
was 5.6 mm (±1.4) in group C and 6.6 mm (±2.4) 
in group LO (P = 0.18). The mean of VA before the 
operation was observed as 0.3 (±0.3) in group C, while 
this was 0.6 (±0.3) in group LO (P = 0.04). Even 
though the differences between some of the variants were 
significant in this analysis but considering the design 
of our study, that is, changing the technique from C to 
LO and achieving more experience steadily, the clinical 
interpretation of the differences could be debated.
Outcome of surgery
The tumor recurrence was observed in four 
cases (33.3%) of the group C, and eight cases (10.5%) 
in group LO (P = 0.05). The matter of increased 
‘expertise of the surgeon’ could not be evaluated in this 
study because the follow up periods have not been equal 
between the more recent cases and those operated during 
the previous 5‑year interval. The difference between Uex 
after operation compared to Uex prior to operation was 
4.91 mm (±1.3) in group C and ‑5.2 mm (±1.9) in 
the group LO (P = 0.52). The degree of improvement 
in VA noted after operation was 0.08 (±0.2) in group C 
and ‑0.02 (±0.2) in the group LO (P = 0.14).
Complications of surgery
The frequency of neurological deficit was lower 
in group LO than the group C, that is, 25.0% vs. 
75.0% (P = 0.001). Tumor growth was also less frequent 
in the group LO compared with the group C (31.6% vs. 
75.0%) (P = 0.008). Enophthalmos (En) was noted in 
four cases (5.3%) who had LO surgery, while this problem 
was not observed in any case of group C.
Table 4: Comparison of study variables between the two 
surgical techniques
Variables Craniotomy 
(n=12)
Lateral 
orbitotomy 
(n=76)
P value
Demographic variables
Sex (female) 11 (91.7) 46 (60.5) 0.05
Age (year) 47.0 (15.3) 45.6 (13.3) 0.76
Tumor characteristic
Tumor side (right) 5 (41.7) 37 (48.7) 0.65
Invasion to bone 10 (83.3) 43 (56.6) 0.03
Grade of tumor invasion 0.007
Low 6 (50.0) 66 (86.8)
Medium 3 (25.0) 4 (5.3)
High 3 (25.0) 6 (7.9)
Signs and symptoms
Duration of symptom (month) 47.0 (47.3) 43.3 (38.7) 0.80
Pain 5 (41.7) 25 (32.9) 0.53
Redness 0 (0) 5 (6.6) 1.0
Retinal shunt 0 (0) 5 (6.6) 1.0
Exophtalmos before 
operation (mm)
5.6 (1.4) 6.6 (2.4) 0.18
Visual acuity before 
operation (0 to 1)
0.3 (0.3) 0.6 (0.3) 0.04
Surgery outcomes
Recurrence 4 (33.3) 89 (10.5) 0.05
Exophtalmos cure (mm) −4.91 (1.3) −5.2 (1.9) 0.52
Visual acuity 
improvement (0 to 1)
0.08 (0.2) −0.02 (0.2) 0.14
Surgery complications
Neurological deficit 9 (75.0) 19 (25.0) 0.001
Tumor growth 9 (75.0) 24 (31.6) 0.008
Enophtalmos 0 (0) 4 (5.3) 1.0
Table 5: Determinants of the outcome variables
Variables B SE P value
Tumor recurrence
Surgery technique −0.74 0.83 0.37
Post operation radiotherapy 0.73 0.82 0.37
Sex −0.82 0.90 0.92
Age 0.02 0.03 0.44
Tumor side −0.15 0.70 0.82
Invasion to bone 1.98 1.13 0.08
Grade of tumor invasion 0.23 0.49 0.63
Duration of symptom (month) −0.008 0.01 0.47
Duration of post‑operation follow up 0.005 0.004 0.18
Exophtalmos cure
Surgery technique −0.39 0.63 0.54
Post operation radiotherapy 0.51 0.51 0.31
Sex −0.44 0.47 0.34
Age 0.006 0.01 0.69
Tumor side −0.04 0.40 0.92
Invasion to bone −0.61 0.44 0.17
Grade of tumor invasion 0.44 0.36 0.22
Duration of symptom (month) −0.008 0.006 0.17
Duration of post‑operation follow up 0.002 0.002 0.47
Visual acuity improvement
Surgery technique −0.15 0.08 0.08
Post operation radiotherapy −0.01 0.07 0.83
Sex 0.06 0.06 0.34
Age 0.001 0.002 0.81
Tumor side −0.06 0.05 0.25
Invasion to bone −0.02 0.06 0.74
Grade of tumor invasion −0.02 0.04 0.58
Duration of symptom (month) −0.001 0.001 0.15
Duration of post‑operation follow up 8.796E‑5 0.000 0.76
Exophtalmos cure −0.001 0.01 0.96
B: Beta, as the regression coefficient indicating the strength of association. Positive B 
shows a positive association between dependent and independent variables, and negative 
B reveals a negative association. SE stands for standard error of B. SE: Standard error
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Tumor growth after the operation correlated positively 
with tumor invasion to bone (P < 0.001), as it occurred 
in 50.9% and 17.1% of cases with and without tumor 
invasion to bone according to the histopathological 
reports, respectively. It occurred in 88.9% of high‑grade, 
71.4% of medium‑grade, and only 27.8% of low‑grade 
bone infiltrations [Table 3].
Results of the multiple regression analyses
Table 5 demonstrates that the technique of surgery, 
adjusted for other variables, was not associated with 
any of the outcome variables significantly, however, 
as seen from [Table 6], the frequency of neurological 
deficit, which occurred in the cases operated by the LO 
technique, was lower (P < 0.006). The intention to treat 
the cases using LO technique rather than C technique, 
and the learning ladder of surgeon gaining more expertise 
without equal follow‑up period in all the cases, can make 
the clinical interpretation of these outputs difficult.
DISCUSSION
Epidemiology
Sex distribution in our series was 31 men and 57 
women (M/F ratio of 1/1.8), which are remarkably 
different from other reports showing ratios between 
1/3 and 1/15 with an average of 1/3 to 5.[11,20,21,32,39,44,46] 
We encountered only one similar report from China[26] 
with M/F ratio of 1/1.5. That might suggest that women 
with minimal symptomatology, that is, only asymmetric 
eyes and bulging of the temporal region, which can be 
covered easily by the hair or scarf, come very late or even 
never for medical consultation. Another reason for such 
an increase of this subgroup of patients might be that 
other benign ossifying lesions such as fibrous dysplasia 
and osteoma have been diagnosed incorrectly and further 
precise investigations were not performed in such cases.
The cause of hyperostosis
Hyperostosis frontalis interna, osteoma, focal 
erythroid hyperplasia, fibrous dysplasia, osteoblastic 
metastasis to the SW, sarcoidosis, and Paget disease 
are the main pathologies leading to hyperostosis in 
this region.[6,20] Looking for the thin layer of ePN 
enhancing after contrast material injection in CT and 
MRI have not been the main reason to differentiate 
various types of lesions in this location. Inward bulging 
of the hyperostotic SW into the orbit and raggedness 
of the postero‑latero‑temporal aspect of the SW just 
underneath the en plaque tumoral layer are another 
specific characteristic of ePM in this location.[5,9,12,20,25,28] 
We detected this finding in the imaging of all our cases. 
The diploic component of the hyperostotic bone had 
nonspecific characteristics both in CT scans and MRI that 
could not match the histopathologic findings in our cases, 
which is also suggested by others.[9,11,22,28,32,43‑46] We tried 
to tabulate the type of tumor infiltration of the adjacent 
hyperostotic bone to ‘high’, ‘medium’, and ‘no’ infiltration 
according the different samples taken during surgery and 
submitted separately for histopathological examination 
but the differences were not of significance [Table 3].
Imaging evaluation
Extensive neuroimaging assessments are necessary 
including: (a) High‑resolution CT scans with contrast 
material injection to evaluate bone as well as soft tissue 
involvement. Thin‑cut coronal bone CT scan were taken 
with 3‑dimensional reconstruction (3D recon) not only to 
detect even a small amount of hyperostosis but also to 
simplify surgical planning, (b) good resolution MRI with 
gadolinium enhancement done with fat‑suppression and 
other possible sequences to detect any soft tissue tumor 
infiltration. Different authors have classified hyperostosis 
of SWMs into four types: Homogeneous, periosteal, 
layered, and diploic.[22,32,41,43] No such a differentiation was 
possible in our series of 88 cases and we encountered soft 
tissue tumor enhancement in the temporal, intraorbital, 
para‑pharyngeal, and extra‑temporal fossae underneath 
the temporalis muscle. Considering the possible impact 
of these different types of tumor extension, we tried 
another simple practical grading of tumor infiltration 
mentioned in table 1.
Symptoms and their oncologic pathogenesis
The most common clinical presentation of ePMSW is 
Uex. Their Ex is usually slowly progressing, nonpulsating, 
Table 6: Determinants of the surgery complications
Variables B SE P value
Neurological deficit
Surgery technique −2.25 0.82 0.006
Post operation radiotherapy −0.45 0.63 0.94
Sex −0.05 0.60 0.92
Age −0.01 0.02 0.53
Tumor side −0.57 0.52 0.27
Invasion to bone 0.31 0.57 0.58
Grade of tumor invasion 0.20 0.44 0.63
Duration of symptom (month) 0.01 0.007 0.12
Duration of post‑operation follow up −0.002 0.003 0.38
Tumor growth
Surgery technique −12.85 7080.71 0.99
Post operation radiotherapy 167.27 12507.78 0.99
Sex −58.13 9918.82 0.99
Age 0.05 503.64 1.00
Tumor side −52.77 5159.41 0.99
Invasion to bone 3.97 4759.40 0.99
Grade of tumor invasion 23.54 11092.49 0.99
Duration of symptom (month) 0.46 41.88 0.99
Duration of post‑operation follow up 0.02 19.69 0.99
B: Beta, as the regression coefficient, SE: Standard error of B
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irreducible, and painless. Hyperostosis of the elements 
of the SW, invasion of the tumor to the periorbita, 
intraorbital tumor extension, and venous stasis of both 
superior and inferior orbital veins are the main causes 
of these symptoms. Decreased vision, diplopia, ptosis, 
headache, and seizure may develop later in the course 
of the illness.[3,14,20,35] Decreased vision was present in 
65 (75%) of our cases and the other complaints were less 
frequent [Table 2]. Unilateral visual loss is mostly due 
to narrowness of the optic foramen.[3,34] Compression 
of the optic nerve by the tumor both within the cone 
of the orbit and just besides the cranial side of the 
optic foramen without hyperostosis of ACP has been 
another factor in one‑third of our cases. There has been 
no significant relation between the amount of the soft 
tumor tissue and the degree of hyperostosis in these cases, 
as also reminded by others.[3,34,42] The amount of tumor 
infiltration within the adjacent hyperostotic bone in 
our series [Tables 3 and 4] does not match and reflect 
those mentioned in the available literature.[14,20,21,27,32,41] 
We tried to collect all the specimens from wherever the 
hyperostotic bone was seen. The specimens from the 
lesser and the greater wings were studies both from the 
superficial portions besides the soft tumoral tissue and 
from the deeper hyperostotic bone separately. Of the 
12 cases with clinoidal hyperostosis, 4 contained tumor 
cells and 8 did not [Table 3]. This finding is in contrary 
with other reports.[2,5,18,20,34,44] As mentioned by all 
master surgeons working in this area, collecting not 
enough amount of specimens from deeply located 
hyperostotic bone has been the main drawback for 
critical evaluation of this region.[3,35,39] We have done 
our best to collect specimens step by step while drilling 
the deep bony structures in every layer. Delicate sample 
collection made it possible to examine each layer of 
hyperostosis for possible tumor infiltration [Table 3]. Full 
decompression of the hyperostotic bone and soft tumoral 
tissue in our series led to subsidence of Ex in nearly all 
the patients (the difference between C and LO groups, 
P = 0.54, Table 5), and improvement of vision in 39 out 
of 65 cases (60%, Table 2) (the difference between C and 
LO, P = 0.08, Table 5).
All the tumors in our series were of meningotheliomatous 
type, WFNS grade I. Consequently, there were no 
potential relationship between histological features 
of these tumors and hyperostosis. We have only 
recently started to reexamine the specimens for 
immuno‑histochemical staining and other growth labeling 
indices.
Operative approach
Decompression of the SOF is important for correcting the 
symptoms of Uex in all such cases. In the cases with visual 
impairment, it is strongly recommended to decompress 
the optic canal too.[34] SW meningiomas with extension 
to the orbit currently are removed through several 
transcranial approaches, including supra‑orbital–pterional, 
frontotemporal–orbito‑zygomatic, fronto–orbito–malar, 
and pterional.[2,6‑8,11,14,15,21,26,27,30,32,35,38,41,44,45] Performing 
standard frontotemporal (pterional) craniotomy, it is only 
possible to remove the greater wing of the sphenoid ridge 
down to the lateral limit of the lesser wing and not any 
deeper in the medial direction. The hyperostotic lateral 
wall of the orbit, which is mainly composed of the greater 
SW, can be drilled out from above and lateral side but 
the deeply located toughly ossified parts below the SOF, the 
floor of the temporal fossa, besides the cavernous sinus and 
in front of the foramen Ovale can be reached more easily 
when reached from the lateral side and from below in this 
mini approach [Figure 2]. Accordingly, as in ‘deep lateral 
wall decompression’ technique performed in cases with 
Graves’ disease, the door lamb of the greater wing of the 
sphenoid and the basin of the inferior orbital fissure could 
be removed as much as needed [Figure 3].[3,4,17,27,28,40]
Historical background and comparison of 
technical points
In our communication, we present a series of 88 patients 
harboring SW meningioma with extension into the 
lateral or superolateral orbital compartments. Seventy‑six 
underwent tumor resection via LO approach coupled with 
extensive resection of all components of the hyperostotic 
SW, thus avoiding formal craniotomy.
In 1889, Kronlein first proposed a lateral approach to the 
orbit, and in 1953 he modified the lateral incision from a 
“horseshoe” osteoplastic type to a transverse one extending 
posteriorly from the lateral canthus for 30–35 mm. 
There have been some other modifications in these 
techniques.[23,28,30,35] We curved the incision superiorly up 
to the eyebrow [Figure 1] and have not transected the 
lateral canthal ligament or detached the lateral rectus 
muscle as advocated by others.[3,24,28] With this type of 
skin incision, the surgeon is able to approach tumors in 
the superior lateral, and inferior intraconal compartments, 
the apex of the orbit and posteriorly, the temporo‑basal 
dura can be exposed up to the inferior frontal region. The 
hyperostotic bone located underneath the SOF cannot 
be drilled out from above and lateral aspect without 
changing the craniotomy to zygomatic or any variant of 
laterobasal approaches as mentioned by Dolence et al.[21,30] 
In our modified lateral approach, the hyperostotic lesser 
and greater wings, most of the hyperostotic clinoidal 
process, sufficient amount of the roof of the orbit and 
most of the involved bone back to the cavernous sinus, 
foramen Rotundum and Ovale can be drilled out under 
good visualization extradurally [Figure 7].
Even though complete bony decompression is achievable 
in this way and excision of the soft tumor tissue looks to 
be more precise using microdissection, (near to Simpson 
grade I in the tripodal types in Table 1), but we did 
not proceed for removing the tumor infiltration from 
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within the dural leaflets of SOF in any one of our cases. 
Accordingly, we believe that all our cases ended with 
Simpson grade I to II level of tumor excision.[39]
Reconstruction technique and cosmesis
Depending on the extent of resection of the wall and 
roof of the orbit, most authors who performed these 
variants of craniotomy procedures recommend firm 
reconstruction of the orbital walls to avoid pulsating En 
and diplopia.[16,19,25,30,38] We consider reconstruction of the 
hyperostotic lateral orbital wall and temporal bone to be 
unnecessary in nearly all the cases operated using lateral 
orbital mini‑approach. The rate of improvement of Uex 
was good and the occurrence of En was nil even though 
statistically insignificant (P = 0.52, Table 4) [Figure 7].
By mini‑approach, we do not intend to apply the term 
of “minimally invasive” technique. Removing as much 
bone to change the aspects of an ePMSW to a convexity 
meningioma, via the incision placed partly in the face is 
better not to be coined as “minimally invasive.”
Repairing the dura mater by autologous fascia, fat, and 
Gelfoam or Surgicel was sufficient in all of our cases and 
no disfiguring or pulsating En, fistula or meningocele 
were encountered in long‑term follow up.
The issue of severe atrophy of the temporalis muscle 
occurred in 4/76 cases with LO mini‑approach but 
2/12 with C approach [Table 2]. To prevent such a 
complication, it is advised to: (a) Take care of the feeding 
arterial branches of the temporalis muscle and (b) release 
the traction applied upon the muscle while drilling the 
hyperostotic bone, microscopic fine excision of the ACP, 
and tumor excision is being done.
It looks disturbing that all or part of the scar is visible on 
the face and is not covered by hair. Half of the incision 
used for this approach is located within the eyebrow 
and the other half (at most 3–3.5 cm) is located along 
the maxilla, which is best be sutured in a subcuticular 
manner.
Role of adjuvant radiotherapy
Thirty‑two of the cases in this series received adjuvant 
radiotherapy for control of tumor residue, which was 
resected to Simpson grade II level. FRT is an accepted 
modality of treatment in SOMs as suggested by 
different authors.[28,31,33,39,41] We delivered FRT by 40–50 
(average 45) Gy in 1.8‑Gy fractions only in the cases 
in whom the surgeon believed in invasive nature of 
the ePM either radiologically [Table 1], surgically, or in 
follow‑up examinations. The low recurrence rate in our 
series suggest that on time postoperative radiotherapy 
may provide better control of tumor growth (Table 6, 
P = 0.99).[1,16,18,36] No patient developed radiation‑induced 
retinopathy or any pituitary insufficiency.
Limitations
We could not evaluate the impact of increasing expertise 
of the surgeon in surgically handling the cases during 
specific periods of time regarding the inequality between 
the numbers of cases undergoing surgery each year and 
the differences in the exact follow‑up intervals.
CONCLUSION
Messages in this study can be:
• A smaller (mini‑) LO approach without pterional or 
orbito‑basal craniotomy can be promising and enough 
for removal of hyperostosing SW meningiomas with 
orbital involvement in most of the cases (P = 0.54)
• This approach may be nominated as ‘less invasive’ 
due to smaller skin incision with most of it 
hidden within the eyebrow. The tumor can be 
exposed as a convexity meningioma without 
fronto‑parieto‑temporal craniotomy. Hereby, only the 
involved/reactive bone is removed. Bone should be 
excised as maximally as possible both to decompress 
the orbit appropriately and to minimize the chance 
of tumor recurrence (P = 0.37)
• A selected group of SWMs with tumor extension in 
the anterior part of the temporal fossa and in the 
lateral or superomedial compartment of the orbital 
cavity and ACP can be successfully approached 
through LO approach, thus avoiding craniotomy. In 
these cases, this minimally invasive procedure allows 
removal of the tumor mass and the infiltrated bone, 
with good clinical and cosmetic result (P = 0.97). 
Extension of the tumor mass medial to the axis of the 
optic nerve into the paranasal sinuses is considered 
the cut‑off point for further dissection regarding the 
benign nature of the pathology and acceptable tumor 
control interval
• The thickened bone of the SW is not necessarily the 
origin of the tumor or infiltrated by the tumor (63%) 
Figure 7:  (a) Showing the minimal cosmetic effect of the incision 
on the face and (b and c) the amount of bone work performed 
deep to the skull base region without bone reconstruction in 
3DRCTS. Minimal displacement of the bone strut did not produce 
any disfiguring 
c
ba
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but it can be a reactive sclerosing bone (27%)
• This surgical technique is certainly not advised in 
cases with a large, carpet like dural tumor growth 
extending over the convexity or passing midline in 
the skull base region
• It is suggested that the RIePM should be excluded 
from the standard grading system of SOMs (ePM) 
in future classifications of mid skull base 
meningiomas.
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